Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease

por Christine, Chadwick W., Bankiewicz, Krystof S., Van Laar, Amber D., Richardson, R. Mark, Ravina, Bernard, Kells, Adrian P., Boot, Brendon, Martin, Alastair J., Nutt, John, Thompson, Marin E., Larson, Paul S.
Publicado 2019

Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease

por Nutt, John G., Curtze, Carolin, Hiller, Amie, Anderson, Shannon, Larson, Paul S., Van Laar, Amber D., Richardson, R. Mark, Thompson, Marin E., Sedkov, Alexander, Leinonen, Mika, Ravina, Bernard, Bankiewicz, Krystof S., Christine, Chadwick W.
Publicado 2020

Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial

por Christine, Chadwick W., Richardson, R. Mark, Van Laar, Amber D., Thompson, Marin E., Fine, Elisabeth M., Khwaja, Omar S., Li, Chunming, Liang, Grace S., Meier, Andreas, Roberts, Eiry W., Pfau, Madeline L., Rodman, Josh R., Bankiewicz, Krystof S., Larson, Paul S.
Publicado 2022